Design and evaluation of indole-based hydrazones targeting heparanase with cytotoxic activity in human breast cancer cells

Abstract Heparanase, an endoglycosidase implicated in tumour growth, invasion, and metastasis,​ remains an attractive target for anticancer drug discovery. In this study, a series of indole-based hydrazones was designed to target heparanase with potential anticancer inhibition in breast cancer cells. Structure-based analyses, including molecular docking and molecular dynamics simulations, suggested that several derivatives can interact with residues in the heparanase binding region, including recurrent contacts involving GLU 225, GLN 270, HIS 296, TYR 298, and TYR 348. In silico ADME profiling indicated generally acceptable drug-like properties for the designed series. The designed compounds were synthesized and characterized by FTIR, 1 H NMR, 13 C NMR, and HRMS, and conformational features were further examined by DFT studies. Among the synthesized compounds evaluated for heparanase inhibition using the HTRF assay, derivative E showed the highest apparent inhibitory response; however, its activity remained substantially weaker than that of the reference inhibitor PG545 and lacked a clear dose-dependent trend, indicating only modest inhibitory potential. Furthermore, cytotoxicity testing in MCF-7 breast cancer cells identified compound A as the most active compound, with an IC 50 value of 2.078 µM. Overall, these results identify indole-based hydrazones as preliminary scaffolds for further optimization toward heparanase-related anticancer applications.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-17
DOI
https://doi.org/10.1038/s41598-026-78838-y
Primary Topic
Heterocyclic Compound Synthesis and Bioactivity
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Design and evaluation of indole-based hydrazones targeting heparanase with cytotoxic activity in human breast cancer cells

M Padmapriya, Rajeev K. Sinha, Erik W. Thompson, Narasimha Murthy Beeraka et al.
2 links
Scientific Reports
Heterocyclic Compound Synthesis and Bioactivity
article

Design and evaluation of indole-based hydrazones targeting heparanase with cytotoxic activity in human breast cancer cells

M Padmapriya, Rajeev K. Sinha, Erik W. Thompson, Narasimha Murthy Beeraka, Peter Edward Lobie, Vladimir Nikolaevich Nikolenko, Neha S. Gandhi, Mamatha Sindhuvalli Kempasiddegowda, Santosh L. Gaonkar, Basappa Basappa, R. Manjunath, Alan K. L. Toh
article en

Abstract

Abstract Heparanase, an endoglycosidase implicated in tumour growth, invasion, and metastasis,​ remains an attractive target for anticancer drug discovery. In this study, a series of indole-based hydrazones was designed to target heparanase with potential anticancer inhibition in breast cancer cells. Structure-based analyses, including molecular docking and molecular dynamics simulations, suggested that several derivatives can interact with residues in the heparanase binding region, including recurrent contacts involving GLU 225, GLN 270, HIS 296, TYR 298, and TYR 348. In silico ADME profiling indicated generally acceptable drug-like properties for the designed series. The designed compounds were synthesized and characterized by FTIR, 1 H NMR, 13 C NMR, and HRMS, and conformational features were further examined by DFT studies. Among the synthesized compounds evaluated for heparanase inhibition using the HTRF assay, derivative E showed the highest apparent inhibitory response; however, its activity remained substantially weaker than that of the reference inhibitor PG545 and lacked a clear dose-dependent trend, indicating only modest inhibitory potential. Furthermore, cytotoxicity testing in MCF-7 breast cancer cells identified compound A as the most active compound, with an IC 50 value of 2.078 µM. Overall, these results identify indole-based hydrazones as preliminary scaffolds for further optimization toward heparanase-related anticancer applications.

Scientific Reports
Birla Institute of Technology, Mesra (IN), Translational Research Institute (AU), Queensland University of Technology (AU), Manipal Academy of Higher Education (IN), Sechenov University (RU), University of Mysore (IN), Shenzhen Bay Laboratory (CN), Tsinghua Shenzhen International Graduate School (CN), Manipal University Jaipur (IN), Saveetha University (IN), Tsinghua University (CN)
National Natural Science Foundation of China, Tsinghua Shenzhen International Graduate School
Good health and well-being
Heterocyclic Compound Synthesis and Bioactivity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon